CALB2 and Miyoshi myopathy: As a marker panel is more significant than a single marker for the diagnosis of MM [7], [48], it may be useful to evaluate miR-103 in combination with other biomarkers like SMRP [49] or calretinin [36] to improve sensitivity and specificity.